Synonyms: Apretude® | CAB | Cabenuva® (cabotegravir + rilpivirine) | GSK-1265744 | GSK1265744 | GSK744 | Vocabria®
cabotegravir is an approved drug (EMA (2020), FDA (2021))
Compound class:
Synthetic organic
Comment: Cabotegravir (GSK1265744, CAB) is a long-acting HIV integrase inhibitor. It is structurally related to dolutegravir.
|
|
No information available. |
Summary of Clinical Use ![]() |
Cabotegravir can be administered alone (orally), or in combination with rilpivirine as a long-acting injection that is administered monthly. |
External links ![]() |
For extended ADME data see the following: European Medicines Agency (EMA) |